Concepedia

A phase II study of ZD6474 (Zactima™), a selective inhibitor of VEGFR and EGFR tyrosine kinase in patients with relapsed multiple myeloma—NCIC CTG IND.145

Michael J. Kovacs, Donna Reece, Deborah Marcellus, Ralph M. Meyer, Sarah Mathews, Rui-Ping Dong, Elizabeth A. Eisenhauer

Investigational New Drugs · 2006 · 75 citations · 36 references

DOI

Concepts

References

36

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

Paul G. Richardson, Bart Barlogie, James R. Berenson et al. · New England Journal of Medicine · 2003 · 2.6K citations · Full text

, , +10

Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

Seema Singhal, Jayesh Mehta, Raman Desikan et al. · New England Journal of Medicine · 1999 · 2.6K citations · Full text

, , +14

A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

Michel Attal, Jean‐François Rossi, Philippe Casassus et al. · New England Journal of Medicine · 1996 · 2.6K citations · Full text

, , +14

Risk Factors for Doxorubicin-lnduced Congestive Heart Failure

Daniel D. Von Hoff · Annals of Internal Medicine · 1979 · 2.4K citations

, , +15

Congestive heart failure in patients treated with doxorubicin

Sandra M. Swain, Fredrick S. Whaley, Michael S. Ewer · Cancer · 2003 · 2.3K citations · Full text

, , +15